Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,951–5,975 of 7,816 matching trials · page 239 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Empowerment Intervention for Persons With Young Onset Dementia NCT02937883 Empowerment intervention Runs in: Netherlands · 1 site |
NA other |
COMPLETED | 60 | Radboud University Medical Center OTHER |
2018-09-04 |
|
To Evaluate the Efficacy and Safety/Tolerability Profiles of G-CSF in Subjects With Mild to Moderate Alzheimer's Disease NCT03656042 Filgrastim (75mcg/0.3ml) Runs in: Taiwan · 1 site |
PHASE2 other |
COMPLETED | 21 | Chang Gung Memorial Hospital OTHER |
2018-09-04 |
|
Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation NCT01958437 Transcranial direct current stimulation (tDCS) Runs in: United States · 2 sites |
NA other |
COMPLETED | 44 | VA Office of Research and Development OTHER_GOV |
2018-08-31 |
|
Comprehensive Home-based Dementia Care Coordination for Medicare-Medicaid Dual Eligibles in Maryland NCT02395731 MIND at Home-Plus Intervention Runs in: United States · 1 site |
NA other |
COMPLETED | 342 | Johns Hopkins University OTHER |
2018-08-31 |
|
Guilingji Capsule for Mild-to-moderate Cognitive Impairment NCT03647384 Gulingji capsules; Ginko Biloba Extract tablet Runs in: China · 1 site |
PHASE2 other |
UNKNOWN | 348 | Xiyuan Hospital of China Academy of Chinese Medical Sciences OTHER |
2018-08-27 |
|
M-learning to Improve Professional Competencies in Health Sciences NCT03335397 M-learning application; Traditional learning process Runs in: Spain · 1 site |
NA other |
COMPLETED | 100 | Universidad de Granada OTHER |
2018-08-24 |
|
Alzheimer's Disease: Therapeutic Potential of Estrogen NCT00066157 Transdermal estradiol; Medroxyprogesterone; Placebo Patch; Placebo Runs in: United States · 1 site |
PHASE2|PHASE3 other |
COMPLETED | 42 | University of Wisconsin, Madison OTHER |
2018-08-23 |
|
Evidence Amyloid Scan EEG Study NCT03644043 EEG scan Runs in: United States · 1 site |
NA other |
UNKNOWN | 2,000 | Metabolic Therapy Inc. OTHER |
2018-08-23 |
|
The Effect of Blood Pressure on the Postoperative Cognitive Dysfunction NCT02536885 Liberal group; Restrictive group Runs in: Czechia · 1 site |
NA other |
COMPLETED | 100 | University Hospital Hradec Kralove OTHER |
2018-08-22 |
|
Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations NCT02928211 Sapphire II; Aftobetin-HCl; Positron Emission Tomography Runs in: United States · 1 site |
PHASE1 other |
UNKNOWN | 105 | Cognoptix, Inc. INDUSTRY |
2018-08-22 |
|
Delirium in Home-dwelling Old People Receiving Home Nursing Care NCT03066232 Runs in: Norway · 1 site |
NA other |
COMPLETED | 211 | Oslo University Hospital OTHER |
2018-08-22 |
|
The Depression in Alzheimer's Disease Study (DIADS) NCT00009191 Sertraline [Zoloft] Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | — | Johns Hopkins University OTHER |
2018-08-20 |
|
Pharmacological Management of Delirium NCT00842608 Reduced exposure to anticholinergics; Reduced exposure to benzodiaz... Runs in: United States · 3 sites |
NA other |
COMPLETED | 551 | Indiana University OTHER |
2018-08-17 |
|
EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors NCT02623764 |
NA symptomatic-cholinergic |
UNKNOWN | 218 | Landspitali University Hospital OTHER |
2018-08-17 |
|
Differential Effects of Various Anesthetic Agents on Cognitive Function in Patients With Alzheimer's Disease NCT01870453 Runs in: United States · 1 site |
NA other |
WITHDRAWN | 0 | Massachusetts General Hospital OTHER |
2018-08-16 |
|
The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions NCT03631238 Blood sampling for total cholesterol and homocysteine and cognitive... Runs in: Egypt · 1 site |
NA other |
COMPLETED | 41 | Assiut University OTHER |
2018-08-16 |
|
Piedmont Aging, Cognition & Exercise Study-2 NCT02312843 Exercise/Aerobic; Exercise/Stretching Runs in: United States · 1 site |
NA other |
COMPLETED | 33 | Wake Forest University OTHER |
2018-08-15 |
|
Treatment of Traumatic Brain Injury With Hyperbaric Oxygen Therapy NCT00810615 Hyperbaric oxygen @ 2.4 ATA; Sham treatment |
PHASE1|PHASE2 other |
COMPLETED | 50 | San Antonio Military Medical Center OTHER_GOV |
2018-08-13 |
|
MindfulGarden in Treatment of Hyperactive Delirium in a Hospital Setting NCT03621228 MindfulGarden |
NA other |
UNKNOWN | 24 | Simon Fraser University OTHER |
2018-08-13 |
|
Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia NCT01565642 Goals of care decision support Runs in: United States · 1 site |
NA other |
COMPLETED | 302 | University of North Carolina, Chapel Hill OTHER |
2018-08-10 |
|
Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease NCT02079246 Idalopirdine 60 mg Runs in: Argentina; Belgium; Brazil; Bulgaria; Canada; Chile; Croa... · 258 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 1,463 | H. Lundbeck A/S INDUSTRY |
2018-08-10 |
|
Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease NCT03624842 Trappsol (R) Cyclo (TM) |
NA other |
NO_LONGER_AVAILABLE | — | Cyclo Therapeutics, Inc. INDUSTRY |
2018-08-10 |
|
Macronutrient Effects on Alzheimer's Disease (MEAL-2) NCT02463084 Low Diet; High Diet Runs in: United States · 1 site |
NA other |
COMPLETED | 60 | Wake Forest University Health Sciences OTHER |
2018-08-09 |
|
Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients NCT03613467 VATS lobectomy; Thoracotomy lobectomy Runs in: China · 10 sites |
NA other |
COMPLETED | 2,145 | Tang-Du Hospital OTHER |
2018-08-09 |
|
Adverse Drug Reactions in Older Subjects NCT03623542 Runs in: France · 1 site |
NA other |
COMPLETED | 293 | CHU de Reims OTHER |
2018-08-09 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial